Selection of an Empiric Antibiotic Regimen for Hospital-Acquired Pneumonia Using a Unit and Culture-Type Specific Antibiogram

Journal of Intensive Care Medicine - Tập 20 Số 5 - Trang 296-301 - 2005
David L. Green1
1Sherman Hospital, 934 Center Street, Elgin, IL 60120, USA. [email protected]

Tóm tắt

The objective of this retrospective study was to determine the optimal initial antibiotic regimen for hospital-acquired pneumonia using the frequency and sensitivity of Gram negative microorganisms found in sputum cultures. An antibiogram was constructed and compared with the hospital intensive care unit (ICU) antibiogram. The results yielded 191 microorganisms. The study-generated antibiogram showed that the highest percent susceptible antibiotics for all Gram-negative microorganisms were imipenem (75%) and amikacin (84%). Considering only Pseudomonas aeruginosa, the study-generated antibiogram and the hospital ICU antibiogram showed similar results, piperacillin and amikacin (86% and 82%, respectively, vs 91% and 85%, P = nonsignificant for both). The optimal empiric antibiotic regimen in the surgical ICU is different if directed against all possible microorganisms as opposed to the most prevalent microorganism P aeruginosa. Determining initial empiric antibiotic therapy using an ICU and culture-type specific antibiogram would result in a g reater likelihood that more patients would receive adequate initial antibiotic therapy.

Từ khóa


Tài liệu tham khảo

10.1164/ajrccm.159.4.9807050

10.1164/ajrccm.165.7.2105078

10.1164/ajrccm/142.3.523

10.1007/BF01712153

10.1164/ajrccm.156.1.9607030

10.1378/chest.111.3.676

10.1378/chest.122.1.262

10.1378/chest.120.3.955

Hubmayr RD, 2002, Intensive Care Med, 28, 1521, 10.1007/s00134-002-1514-0

10.1164/rccm.200405-644ST

10.1378/chest.115.1.8

National Committee for Clinical Laboratory Standards, 2000, Analysis and Presentation of Cumulative Antimicrobial Susceptibility Test Data—Proposed Guideline M39-P

Stratton CW, 1993, Clin Ther, 15, 12

10.1001/archsurg.133.10.1041

10.1097/00005373-200010000-00010

10.1016/S0002-9610(00)00320-2

Hindler JF, 2001, Microbiology Frontline, 1, 1

10.1093/jac/49.1.201

10.1093/jac/dkf225

10.1093/jac/dkg298

Brown DL, 2001, J Trauma, 51, 1207

10.1053/srin.2000.20944